The overexpression of another ncRNA, lncRNA VPS9D1-AS1, a potential prognostic marker, can be used to predict poor prognosis in NSCLC (70), and its role in cancer has been validated (71, 72). The gene discussed is VPS9D1; the disease is cancer.